Risk Partners Life Sciences Roundtable 2024, thank you very much! Already for the 26.06.2025 >

Contact us

Growth capital for biotechnology
and life sciences - Finance Day 2024

A few days ago, Jutta and Florian from our team attended Finance Day 2024 at the analytica trade fair in Munich. The event once again offered exciting expert panels on current financing and capital market issues for life sciences companies. As the panels focused on three of our key consulting areas, namely life sciences, venture capital and IPOs, attending was of course a must for us as a specialist insurance broker. Our team was also delighted to meet many of our partners and clients again and talk to them about the importance of risk management and insurance solutions.

The startup panel was also interesting and once again demonstrated the innovative spirit of the industry. Ten companies were selected for this, nine of which were even presented in person by a founder. Take a look at the companies and if you are interested in the product or an investment, please contact the ladies or gentlemen directly. We are keeping our fingers crossed! 

  1. Better Basics Laborbedarf GmbH(Mario Schneider)
  2. Intu Diagnostics GmbH(Dr. Dirk Kuhlmeier )
  3. Pacifico Biolabs GmbH(Washington Logroño)
  4. Dr. Purus Enorm Smart Technik GmbH(Dr. Bo Liu)
  5. goodBot GmbH(Dr. Julius Wiener)
  6. hema.to GmbH(Dr. Karsten Miermanns)
  7. IRUBIS GmbH(Anja Müller)
  8. Opto Biolabs GmbH(Dr. Kathrin Brenker)
  9. Safia Technologies GmbH(Dr. Timm Schwaar)
  10. CamSens GmbH(Enrika Barreto) 
Risk Partners at the Finance Days
Flyer Finance Days 2024

In addition, the challenges of the financing environment were again discussed from various perspectives. The desire for a European capital market that would combine the strengths of Frankfurt, Euronext and NASDAQ Europe was articulated fairly unanimously. From our point of view as a specialist insurance broker, this is also desirable, although the standardization of the liability framework would certainly become even more challenging, so that different solutions for each stock exchange would no longer be necessary, as is currently the case.  

In conclusion, we are delighted to have been part of these events and will be back at the next one in Leipzig. Thanks also to the team of Plattform Life Sciences and Going Public Media AG for the great organization and the successful framework of the event! We had a lot of fun. 

Also read our other blog posts

Being Public

Risk Partners supports successful uplisting of Formycon AG to the Prime Standard

Congratulations to Formycon AG on its successful uplisting to the Prime Standard of Deutsche Börse on November 12, 2024! Welcome to the Prime Standard league: A new champion of life sciences and biosimilars has successfully made the step from the Scale segment. We proudly congratulate Enno Spillner, Dr. Caroline Redeker, Daniel Marquard and the entire Formycon AG team on this great success and another important milestone on their way to becoming a global champion in the field of biosimilars! Formycon AG has focused on

Read more "
November 14, 2024
Being Public

Risk Partners supports successful IPO of Steyr Motors AG

We congratulate Steyr Motors AG on its successful listing in the Scale Segment of the German Stock Exchange on October 30, 2024! Risk Partners had the honor to act as IPO underwriting advisor on this transaction. Our team, led by Florian Eckstein and Björn Stressenreuter, supported Steyr Motors AG in its IPO on the Frankfurt Stock Exchange. Our expertise and comprehensive support were focused on providing Steyr Motors with a safe and successful start on the capital markets. We would like to thank Julian Cassutti and Christoph Cerar from Steyr Motors

Read more "
October 31, 2024
Being Public

Global Integrity and Compliance Forum 2024 

𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝘁𝗲𝗴𝗿𝗶𝘁𝘆 𝗮𝗻𝗱 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝗙𝗼𝗿𝘂𝗺 𝟮𝟬𝟮𝟮𝟰 "D&O and Co. - Plan B to cover personal liability!" Last Friday, Florian had the honor of taking part in the Global Integrity and Compliance Forum at the Ludwig-Maximilians-Universität in Munich. Under the motto "The RULE of LAW in the Era of Integrity & Compliance", international legal experts, company managers, in-house councils and compliance officers from all over the world gathered to discuss the future of good corporate governance in 2024. Key discussions and insights One of the

Read more "
June 14, 2024
Your question has not been answered?
We will be happy to advise you in a free initial consultation.
Get advice now

Receive the Life Sciences Insurance Protection Guide free of charge!

Everything you need to know to optimally protect you and your life sciences / biotech company.